Advertisement

International Journal of Hematology

, Volume 96, Issue 3, pp 364–369 | Cite as

Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation

  • Futoshi IiokaEmail author
  • Ryuichi Sada
  • Yoshitomo Maesako
  • Fumihiko Nakamura
  • Hitoshi Ohno
Case Report

Abstract

We report an outbreak of pandemic 2009 influenza A/H1N1 virus (2009 H1N1) infection that occurred in the hematology ward of our institution during the 2010–2011 influenza season. A total of seven hospitalized patients with hematologic tumors, including five recipients of hematopoietic stem cell transplantation (HSCT), successively developed rapid influenza detection test (RIDT)-positive influenza A; four patients had laboratory-confirmed 2009 H1N1 infection. Three HSCT recipients required mechanical ventilation support and two were admitted to the intensive care unit; they died of progressive respiratory failure despite receiving available anti-viral drugs. We implemented outbreak-control measures including transferal of RIDT-positive patients to a single-patient room and chemoprophylaxis with oseltamivir. We note that the H275Y neuraminidase mutation was detected in respiratory specimens from three patients, who were administered therapeutic or prophylactic dosages of oseltamivir. The present report demonstrates that the nosocomial 2009 H1N1 outbreak in the hematology ward led to fatal clinical outcomes and the emergence of a resistant virus at a markedly high rate.

Keywords

Pandemic 2009 H1N1 influenza virus Nosocomial outbreak Hematopoietic stem cell transplantation Outbreak-control measures H275Y mutation 

Notes

Acknowledgments

The authors wish to thank Dr. Y. Kitahori at the Division of Bacteriology, Nara Prefectural Institute for Hygiene and Environment, for diagnostic testing of 2009 H1N1 infection; and all medical and nursing staff at Tenri Hospital for treating the patients.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Choi SM, Boudreault AA, Xie H, Englund JA, Corey L, Boeckh M. Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood. 2011;117:5050–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010;60:257–63.PubMedCrossRefGoogle Scholar
  3. 3.
    Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus. Aust Emerg Infect Dis. 2010;16:1068–75.CrossRefGoogle Scholar
  4. 4.
    Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–19.PubMedCrossRefGoogle Scholar
  5. 5.
    Infectious Agents Surveillance Center. 2009/2010 influenza season. Jpn IASR. 2010;31:248–50.Google Scholar
  6. 6.
    Wei JY, Chen FF, Jin J, Mai WY, Qian WB, Meng HT, et al. Novel influenza A (H1N1) in patients with hematologic disease. Leuk Lymphoma. 2010;51:2079–83.PubMedCrossRefGoogle Scholar
  7. 7.
    Lalayanni C, Sirigou A, Iskas M, Smias C, Sakellari I, Anagnostopoulos A. Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J Infect. 2010;61:270–2.PubMedCrossRefGoogle Scholar
  8. 8.
    Rihani R, Hayajneh W, Sultan I, Ghatasheh L, Abdel-Rahman F, Hussein N, et al. Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant. 2011;46:1430–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Nieto Campuzano JB. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica. 2011;96:1231–5.PubMedCrossRefGoogle Scholar
  10. 10.
    To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010;50:850–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Infectious Agents Surveillance Center. 2010/2011 influenza season. Jpn IASR. 2011;32:314–6.Google Scholar
  12. 12.
    Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, Tan BH, et al. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med. 2010;362:2166–74.PubMedCrossRefGoogle Scholar
  13. 13.
    Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, et al. Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2011;17:434–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Ljungman P, Avetisyan G. Influenza vaccination in hematopoietic SCT recipients. Bone Marrow Transplant. 2008;42:637–41.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2012

Authors and Affiliations

  • Futoshi Iioka
    • 1
    Email author
  • Ryuichi Sada
    • 2
  • Yoshitomo Maesako
    • 1
  • Fumihiko Nakamura
    • 3
  • Hitoshi Ohno
    • 1
  1. 1.Department of HematologyTenri HospitalTenriJapan
  2. 2.Department of General Internal MedicineTenri HospitalTenriJapan
  3. 3.Department of Clinical PathologyTenri HospitalTenriJapan

Personalised recommendations